NO TO HATTATSU
Online ISSN : 1884-7668
Print ISSN : 0029-0831
ISSN-L : 0029-0831
Search
Advanced search
OR
Browse
Search
Volume 51, Issue 3
Displaying 1-16 of 16 articles from this issue
Show all abstracts
    • |<
    • <
    • 1
    • >
    • >|
Editorial
Review
  • Advances in medical care of congenital cytomegalovirus infection : progress in diagnosis
    Hiroyuki Moriuchi
    2019 Volume 51 Issue 3 Pages 151-156
    Published: 2019
    Released on J-STAGE: May 08, 2019
    DOIhttps://doi.org/10.11251/ojjscn.51.151
    JOURNAL FREE ACCESS
    Show abstractHide abstract

      The greatest advance in medical care of congenital cytomegalovirus (CMV) infection of recent date should be the finding that ganciclovir/valganciclovir therapy is able to improve the prognosis of symptomatic congenital CMV disease. Accordingly, the importance of early definitive diagnosis is reconfirmed, since antiviral therapy started within 30 days of life proved to be effective in those studies. Recently, an in vitro diagnostics that amplifies and measures CMV DNA in urine specimens collected within 21 days of life was developed and approved for coverage by medical insurance. Unfortunately, however, many patients with congenital CMV infection still remain undiagnosed. CMV screening targeting neonates who failed neonatal hearing screening will be useful to find those with congenital CMV infection who may benefit from early diagnosis and therapeutic intervention.

    View full abstract
    Download PDF (482K)
Special Issue for the 60th Annual Meeting of the Japanese Society of Child Neurology
<Symposium 1 : Acute encephalopathy up-to-date>
<Symposium 9 : Childhood peripheral neuropathy for pediatric neurologists>
<Seminar>
Short Communication
    • |<
    • <
    • 1
    • >
    • >|
feedback
 Top